mosapramine has been researched along with Chronic Disease in 1 studies
mosapramine: structure given in first source
mosapramine : A racemate comprising equimolar amounts of (R)- and (S)-mosapramine. It is a second-generation antipsychotic used for the treatment of schizophrenia.
1'-[3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]hexahydro-2H-spiro[imidazo[1,2-a]pyridine-3,4'-piperidin]-2-one : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(2-oxohexahydro-2H-spiro[imidazo[1,2-a]pyridine-3,4'-piperidin]-1'-yl)propyl group.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "There is little information regarding the effects of risperidone addition to neuroleptic treatment in chronic schizophrenia." | 9.09 | Comparison of risperidone and mosapramine addition to neuroleptic treatment in chronic schizophrenia. ( Oga, T; Okada, M; Takahashi, N; Terao, T, 1999) |
| "There is little information regarding the effects of risperidone addition to neuroleptic treatment in chronic schizophrenia." | 5.09 | Comparison of risperidone and mosapramine addition to neuroleptic treatment in chronic schizophrenia. ( Oga, T; Okada, M; Takahashi, N; Terao, T, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takahashi, N | 1 |
| Terao, T | 1 |
| Oga, T | 1 |
| Okada, M | 1 |
1 trial available for mosapramine and Chronic Disease
| Article | Year |
|---|---|
Comparison of risperidone and mosapramine addition to neuroleptic treatment in chronic schizophrenia.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Behavioral Symptoms; Benzazepines; Chronic Diseas | 1999 |